17 August 2026
World Hepatitis Day falls on 28 July each year,¹ and in Australian pharmacy circles the conversation is shifting from awareness to action. More Australian pharmacies are starting to take on hepatitis C testing and treatment, though the number remains small, a shift that also changes what needs to be on hand behind the counter. ²
63% of people in Australia have received hepatitis C cures since 2016. However, there are still nearly 70,000 people living with hepatitis C in Australia.³
The Burnet Institute’s EXPAND-C project is trialling hepatitis C point-of-care testing directly in community pharmacies, using a Therapeutic Goods Administration-approved rapid test device.⁴ Pharmacists involved in the project offer testing, harm reduction guidance and referral to treatment in a single visit.⁴ The project is endorsed by Hepatitis Australia and supports Australia’s national strategy to eliminate hepatitis C as a public health threat by 2030.⁴
Recent research suggests the shift is already underway. A survey of more than 500 Australian community pharmacists found that 22% already stock hepatitis C medications, and close to half said they would be willing to host an outreach HCV testing team on-site.⁵ Willingness was notably higher among pharmacists in rural and remote areas, where access to specialist services is often more limited.⁵
Expanding into testing and screening services changes a pharmacy’s usual order list. Point-of-care test kits, associated consumables and specialty medications aren’t always part of a pharmacy’s regular ordering pattern, and sourcing them can mean chasing down a new supplier relationship for every new product line.
This is where having broad, flexible supplier access matters. connects pharmacies to hundreds of in one place, and shows real-time availability before you commit to an order. For pharmacies exploring a bigger role in hepatitis testing and treatment, or any expanding clinical service, that means adding a new product line doesn’t have to mean adding new administrative overhead.
Footnotes
For any general enquiries
1300 724 579
info@pharmx.com.au
ABN: 25 000 091 305
ACN: 000 091 305
Pharmx © 2026